Treeline Biosciences, Inc.
4 clinical trials · Sponsor
◉ Watch Treeline Biosciences, Inc.
| Record | Firm | Date |
|---|---|---|
| TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors (NCT07713732) | Treeline Biosciences, Inc. | 2026-07-25 |
| TLN-372 in Advanced KRAS Mutant Solid Tumors (NCT07204340) | Treeline Biosciences, Inc. | 2025-09-29 |
| TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas (NCT07082803) | Treeline Biosciences, Inc. | 2025-06-23 |
| A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma (NCT06733441) | Treeline Biosciences, Inc. | 2024-12-16 |
Track Treeline Biosciences, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.